| Website | archimedespharma.com |
| Category | BioTech |
| Phone | +44 (0)118 931 5050 |
| timwatts@archimed... | |
| Employees | |
| Founded | 2004 |
| TOTAL | $99M |
| FUNDING TOTAL | $99M |
| Series C, 4/10 Warburg Pincus Novo A/S | $99M |
Archimedes Pharma Limited operates as a specialty pharmaceutical company. Its products include Gliadel, for high grade glioma; Zomorph, an oral sustained release morphine product for cancer pain; Nozinan that treats nausea and vomiting in cancer patients; Pabrinex, a formulation of vitamins B and C for alcoholics experiencing acute withdrawal; and Nasalfent, an intranasal fentanyl for relief of cancer pain. The company was founded in 2004 and is headquartered in Reading, the United Kingdom. It has operations in the United Kingdom, France, and Germany.
